CClinicalTrials.gg
RecruitingNCT07044427MyfallUpdated Jan 22, 2026

Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients

An interventional study of Strength and balance training in combination with a treadmill-based pertubation intervention in Multiple Myeloma, Fall Risk Factors and Strength Training Effects, sponsored by University Hospital Heidelberg. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by University Hospital Heidelberg · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Feb 2024, registered Jun 2025).
  • Started Feb 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Approximately one third of the population over the age of 65 falls at least once a year. The risk of falling is in increased in older patients with tumor diseases. In addition to high treatment and care costs for the healthcare system, falls often lead to a decrease of quality of life, a reduction in physical performance and a loss of independence. Despite the high risk, falls in cancer patients have not yet been scientifically investigated in detail. For patients with multiple myeloma in particular, very little data is available on the prevalence, risk factors and effects of falls. In this study, a fall risk assessment is carried out in patients with multiple myeloma. Furthermore, a patient-specific training intervention for fall prevention will be implemented.

The aim of the study is to identify possible fall risk factors in multiple myeloma patients and to establish a structured exercise intervention that minimizes the risk of falls and injuries.

02

Conditions studied

  • Multiple Myeloma
  • Fall Risk Factors
  • Strength Training Effects
  • Balance Training Effects

Browse trials for

Keywords

  • Multiple Myeloma
  • Fall risk
  • pertubation training
  • strength training
  • Balance
03

In context

Multiple Myeloma

3,632 studies on the registry are indexed under Multiple Myeloma; 745 are open to participants now.

This study's planned enrollment of 60 is above the median of 41 across 2,907 interventional studies indexed under Multiple Myeloma.

Browse Multiple Myeloma studies →

Lead sponsor

University Hospital Heidelberg is the lead sponsor of 175 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy)
  • ECOG status ≤ 3
  • Age ≥18 years
  • Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits
  • Ability to give informed consent
  • Written consent to participate in the study
  • Sufficient written and spoken German to complete the questionnaire

Exclusion criteria

Exclusion Criteria:

  • Any physical or mental limitations that would prevent participation in the training program or the planned follow-up checks.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Other
    Exercise Intervention

    Fall Prevention

    Other: Strength and balance training in combination with a treadmill-based pertubation intervention

Interventions

  • OtherStrength and balance training in combination with a treadmill-based pertubation intervention

    Patients receive a personalized home-based training plan with strength and balance exercises to be carried out three times a week for six months. In addition, treadmill-based pertubation training is carried out at 2 timepoints.

06

What researchers measure

Primary outcomes

  1. Feasibility of at least 48 out of 72 training sessions with the focus on fall prevention within 24 weeks

    Patients will document the number of training sessions via an online training-app (Physiotec, Bad Wünnenberg, Germany). Feasibility is achieved if 48 of 72 possible training sessions were successfully completed.

    Time frame: From enrollement to the end of the training intervention at 6 months

  2. Effectivity (fear of falling)

    Fear of falling will be evaluated by a validated questionnaire (FES-I, Falls Efficacy Scale-Inernational). The questionnaire contains 16 items scored on a four-point scale (1=not at all concerned to 4=very concerned). Scores \>23 indicate high concern about falling.

    Time frame: Evaluated at the beginning of the study and at the end of the study after 6 months

07

Study locations

1 of 1 sites recruiting
  • University Hospital Heidelberg
    Heidelberg, Baden Würtemberg 69120, Germany
    Recruiting
08

References and documents

Publications

  • Wildes TM, Fiala MA. Falls in older adults with multiple myeloma. Eur J Haematol. 2018 Mar;100(3):273-278. doi: 10.1111/ejh.13009. Epub 2018 Jan 8. PubMed 29239009 ↗
  • Wildes TM, Dua P, Fowler SA, Miller JP, Carpenter CR, Avidan MS, Stark S. Systematic review of falls in older adults with cancer. J Geriatr Oncol. 2015 Jan;6(1):70-83. doi: 10.1016/j.jgo.2014.10.003. Epub 2014 Oct 30. PubMed 25454770 ↗
  • Dapunt U, Ehret P, Paratte JL, Kuehl RM, Wiskemann J, Jager D, Muller-Tidow C, Raab MS, Goldschmidt H. A precision-based exercise program for patients with multiple myeloma. Eur J Haematol. 2023 Dec;111(6):930-937. doi: 10.1111/ejh.14106. Epub 2023 Sep 20. PubMed 37727991 ↗
  • Sattar S, Alibhai SM, Spoelstra SL, Fazelzad R, Puts MT. Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer. 2016 Oct;24(10):4459-69. doi: 10.1007/s00520-016-3342-8. Epub 2016 Jul 22. PubMed 27450557 ↗
  • Pandya C, Magnuson A, Dale W, Lowenstein L, Fung C, Mohile SG. Association of falls with health-related quality of life (HRQOL) in older cancer survivors: A population based study. J Geriatr Oncol. 2016 May;7(3):201-10. doi: 10.1016/j.jgo.2016.01.007. Epub 2016 Feb 18. PubMed 26907564 ↗

Individual participant data

Plan to share: Yes — * questionnaire results collected for each individual * functional test results collected for each individual

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07044427
Lead sponsor
University Hospital Heidelberg
Collaborators
Bethanien Krankenhaus gGmbH
Responsible party
Ulrike Dapunt (Prof. Dr. med., University Hospital Heidelberg) — Principal investigator
First posted
Jul 1, 2025
Start date
Feb 2, 2024
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Jan 22, 2026

Study contacts

Ulrike Dapunt, prof. Dr. med
Contact
ulrike.dapunt@med.uni-heidelberg.de
+49 622156 32765
Dapunt
study chair · University Hospital Heidelberg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion